A detailed history of St Germain D J CO Inc transactions in Novartis Ag stock. As of the latest transaction made, St Germain D J CO Inc holds 5,492 shares of NVS stock, worth $566,060. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,492
Previous 5,492 -0.0%
Holding current value
$566,060
Previous $584,000 8.05%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 02, 2024

SELL
$92.27 - $101.54 $3,506 - $3,858
-38 Reduced 0.69%
5,492 $554,000
Q2 2023

Sep 07, 2023

SELL
$92.52 - $104.91 $71,147 - $80,675
-769 Reduced 12.21%
5,530 $558,000
Q4 2022

Feb 27, 2023

BUY
$75.55 - $92.52 $59,306 - $72,628
785 Added 14.24%
6,299 $571,000
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $5,845 - $6,892
-70 Reduced 1.25%
5,514 $471,000
Q4 2020

Feb 04, 2021

SELL
$78.07 - $94.43 $4,918 - $5,949
-63 Reduced 1.12%
5,584 $527,000
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $9,306 - $10,476
115 Added 2.08%
5,647 $493,000
Q1 2020

May 13, 2020

BUY
$70.67 - $99.01 $2,685 - $3,762
38 Added 0.69%
5,532 $456,000
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $64,021 - $72,385
759 Added 16.03%
5,494 $520,000
Q4 2018

Feb 05, 2019

SELL
$73.66 - $82.02 $2,209 - $2,460
-30 Reduced 0.63%
4,735 $406,000
Q2 2018

Aug 07, 2018

BUY
$64.91 - $73.36 $39,919 - $45,116
615 Added 14.82%
4,765 $360,000
Q1 2018

Apr 20, 2018

SELL
$70.39 - $84.15 $201,104 - $240,416
-2,857 Reduced 40.77%
4,150 $336,000
Q4 2017

Feb 13, 2018

SELL
$72.33 - $77.64 $13,381 - $14,363
-185 Reduced 2.57%
7,007 $588,000
Q3 2017

Oct 31, 2017

BUY
$74.14 - $77.27 $533,214 - $555,725
7,192
7,192 $617,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track St Germain D J CO Inc Portfolio

Follow St Germain D J CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St Germain D J CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on St Germain D J CO Inc with notifications on news.